The Global Pharma Health Fund (GPHF), a non-profit organization supported by Merck KGaA, is pleased to announce the Special Edition 2024, featuring a new Minilab test for detecting the toxic antifreeze agents diethylene glycol (DEG) and ethylene glycol (EG). The GPHF-Minilab is a portable mini-laboratory designed to detect substandard, falsified, and adulterated medicines, especially Read more…
On Friday, 26th July, the FDA, FTFA member USP, and the Asia Pacific Economic Cooperation (APEC) announced the launch of the new web-based version of APEC’s Supply Chain Security (SCS) Toolkit, an essential resource designed to enhance the quality and security of medical products across the global supply chain. Securing Read more…
Join us in confronting a critical issue that affects communities across Africa. Pharmacy students from Guinea, Cameroon, Congo, Ethiopia, Madagascar, and Ivory Coast have come together to expose the harsh truth about fake and substandard medicines. Many of these students were once victims, and now, armed with knowledge, they are Read more…
This playbook provides an overview of the Fight the Fakes Week 2023 campaign and ways to get involved. Download here Download the FRENCH version here. For more information about the Fight the Fakes Week activities visit https://fightthefakes.org/fight-the-fakes-week-4-10-december-2023/
Ce guide fournit un aperçu de la campagne Semaine Fight the Fakes 2023 et propose des moyens de s’impliquer. Téléchargez ici Pour plus d’informations sur les activités de la Semaine Fight the Fakes, visitez https://fightthefakes.org/semaine-fight-the-fakes-4-10-decembre-2023/
The lack of formal training on substandard and falsified (SF) medical products among pharmacists is a significant problem that needs to be addressed to combat the global health threat represented by SF products. A recent study conducted in Sub-Saharan Africa among 355 pharmacy students shows t hat a dedicated educational Read more…
A recent comment written by Oksana Zirka Pyzik (UCL Fight the Fakes academic chapter founder and lead) published by nature reviews highlights how poor-quality or fraudulent medicines are causing extensive humanitarian and economic harm, particularly in Africa. Authors claim these products are a global problem that requires a coordinated cross-border response, including enhanced Read more…
A new study conducted by Vayouly Vidhamaly, Konnie Bellingham, Paul N Newton and Céline Caillet and published in the BMJ Journals shows that substandard and falsified veterinary medicines affect animal health, agricultural production and food security and will influence antimicrobial resistance (AMR) in both animals and humans. According to the authors, Read more…
Image by the Medicine Maker Shabbir Imber Safdar, Partnership for Safe Medicines Executive Director and Fight the Fakes board member, was recently featured in the Medicine Maker online magazine. In his article “Drug Supply Chain Security Act” Shabbir discussed how the US drug supply chain is not immune to falsified medicines Read more…
How misinformation has fuelled the sale of COVID-19 substandard and falsified medical products. A UCL Fight The Fakes lead study written by Oksana Pyzik, Dr. John Hertig, Hoda Kanso, Anika Chamba and Sofia Khan shows there is a strong link between fake news and fake medicines. As waves of COVID-19 continue to threaten public Read more…